Celebrex (celecoxib) is now approved to help reduce the number of intestinal polyps in certain patients

February 2000

Celebrex (celecoxib) is now approved to help reduce the number of intestinal polyps in certain patients.

For now it's only for patients with familial adenomatous polyposis (FAP)...but it's also being studied for non-hereditary colon polyps.

Blocking the COX-2 enzyme seems to reduce the blood supply to the polyp and therefore inhibit growth.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice chart of the significant new drugs approved in 1999
two brand-new quinolone antibiotics
Cardiology whether it's safe to combine a statin with one of the fibrates
Cardiology using niacin for lipids can increase homocysteine levels
Women's Health whether hormone replacement therapy increases the risk of breast cancer
Pediatrics more widespread use of varicella vaccine (Varivax)
Pediatrics new pediatric immunization schedule
Pediatrics new 2-dose regimen for giving Recombivax HB (hepatitis B vaccine) to ADOLESCENTS
Diabetes Humalog Mix 75/25, the first insulin lispro mixture
Diabetes Many patients aren't using their insulin pens correctly
Diabetes alcohol can affect the risk of developing type 2 DIABETES
Dermatology Aldara (imiquimod) cream for refractory common warts and molluscum contagiosum
Alzheimer's Disease possible interaction between Aricept (donepezil) and Paxil (paroxetine)
Alzheimer's Disease high cholesterol might increase the risk of Alzheimer's
Infectious Diseases changes in the recommended dosing for the Lyme vaccine (Lymerix)
Hematology & Oncology Celebrex (celecoxib) is now approved to help reduce the number of intestinal polyps in certain patients
Hematology & Oncology Effexor or Prozac can reduce hot flashes in some oncology patients
Neurology & Pain new anti-epileptic called Trileptal (oxcarbazepine)
Practice FDA just issued important new warnings about Propulsid